BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Hippocampus, Anticancer prodrugs, Lovastatin, rs4950928, IGF1, Allergy to pollen)
Bookmark Forward

QuickView for gamunex (compound)


Genetic Markers

Most Correlated Genes

  1. GSG1L
  2. CADM2
  3. GNAO1
  4. GRIA1
  5. SLITRK5
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. GCM_Q2
  2. postsynaptic density membrane
  3. postsynaptic specialization membrane
  4. integral component of postsynaptic density membrane
  5. integral component of postsynaptic specialization membrane
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Coronary arteries (FFPE) of treated or untreated Kawasaki disease (KD) pediatric patients
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with …
  2. Electrophysiologic correlations with clinical outcomes in CIDP.
  3. Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparati…
  4. Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen…
  5. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE tr…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Prim…
  2. Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Condition…
  3. A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immuno…
  4. Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatme…
  5. A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (G…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.